us patent granted, page-73

opel24v,

"I plan on taking some profits after the initial ***MASSIVE*** re-rate. If OBJ goes belly up after that, so be it, however, I see that as very unlikely. Nothing in life is guaranteed 100%."

I agree. I'll sell 20% at 10c, 20c, 40c, and $1. Then let the last 20% ride. Fingers crossed that OBJ reaches those prices.

gbr,

"I have found in general that when you invest in a company you have faith in the management and how the company is being run, when you lose that faith then it is time to re-consider/evaluate and perhaps move on.

If you have faith, how do you lose it? Faith is faith. The only way you will lose it is if you allow doubt. It's the difference between religion and science. Religion is about faith and science is about doubt. Science starts with open exploration, and when it hits on a theory, it keeps testing and doubting even if it seems perfectly true like Newton's Laws.

"investing is always based upon research not based upon "GSK is involved so it must be good".

I don't say "GSK is involved so it must be good". I say "GSK is involved so it is worth the risk". Big difference. GSK's statement that they are making products with OBJ beats all the research posted here.

Many of the well researched posters here have tried to explain this to you but to no avail"

I understand your position and their position. The problem is that you and others have not understood my position, which I have tried to explain to no avail. It is that proper research of OBJ is not possible for 3 reasons:

1. Most of the important info is carefully hidden.

2. You would need more expertise than the posters here have to research properly.

3. Biotech is rather notorious for supplying dodgy research. Check out this video:

www.ted.com/talks/Ben_goldacre_battling_bad_science.html